Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Reactions02:06

Allergic Reactions

Overview
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Continuous Hemodialysis in Small Neonates With Maple Syrup Urine Disease and Hyperammonemia.

Pediatrics international : official journal of the Japan Pediatric Society·2026
Same author

Characteristics Associated with Infant Feeding with Both Breast Milk and Formula Milk.

Nutrients·2026
Same author

Mucosal-systemic dissociation of IgA responses in egg-allergic toddlers despite regular allergen intake.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same author

Phosphorylation tunes p62 condensates to drive autophagic degradation of ubiquitinated proteins.

The EMBO journal·2026
Same author

Excessive Inflammatory Response to Bacterial Lymphadenitis in an Infant With A Family History of Recurrent Lymph Node Swelling: A Case Report.

Cureus·2026
Same author

CSF Glucose Reduction Before Pleocytosis Documented by Serial Lumbar Punctures in Neonatal Group B Streptococcal Meningitis.

The Pediatric infectious disease journal·2026

Related Experiment Video

Updated: Jul 14, 2026

Measuring Local Anaphylaxis in Mice
07:49

Measuring Local Anaphylaxis in Mice

Published on: October 14, 2014

Real-World Adrenaline Auto-Injector Use During Pediatric Anaphylaxis in Japan: A Single-Center Descriptive Study.

Mariko Inaba1, Yosuke Baba1, Hikaru Tsuchiya1

  • 1Department of Pediatrics, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka, Japan.

Pediatrics International : Official Journal of the Japan Pediatric Society
|July 13, 2026
PubMed
Summary

Pediatric anaphylaxis patients in Japan rarely used prescribed adrenaline auto-injectors (AAIs). Proper education is crucial, emphasizing AAI use for any symptoms, regardless of the specific allergen trigger.

Keywords:
adrenaline auto‐injectoranaphylaxisfirst exposurefood allergypediatrics

More Related Videos

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Published on: April 21, 2019

Related Experiment Videos

Last Updated: Jul 14, 2026

Measuring Local Anaphylaxis in Mice
07:49

Measuring Local Anaphylaxis in Mice

Published on: October 14, 2014

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Published on: April 21, 2019

Area of Science:

  • Pediatric Allergy and Immunology
  • Public Health
  • Emergency Medicine

Background:

  • Adrenaline auto-injector (AAI) prescribing increased in Japan after insurance coverage expansion.
  • Real-world utilization of AAIs during pediatric anaphylaxis is not well understood.

Purpose of the Study:

  • To describe current AAI prescription patterns in Japan.
  • To determine actual AAI utilization rates in pediatric anaphylaxis.
  • To identify factors associated with appropriate AAI use.

Main Methods:

  • Retrospective descriptive study of AAI prescriptions and anaphylaxis hospitalizations (2023-2024) at a tertiary hospital in Shizuoka, Japan.
  • Reviewed 124 AAI-prescribed children and 34 hospitalized anaphylaxis cases.
  • Conducted interviews with 8 hospitalized patients possessing AAIs regarding education and AAI application use.

Main Results:

  • Only 4.0% of AAI-prescribed patients used their device during follow-up.
  • 55.9% of anaphylaxis hospitalizations occurred on first known allergen exposure (92.9% seafood).
  • Only 23.5% of hospitalized patients possessed an AAI; 50% of possessors used it, with higher use (80%) when the triggering allergen matched the prescription.

Conclusions:

  • Low AAI possession and utilization were observed in pediatric anaphylaxis cases in Japan.
  • AAI utilization varied significantly based on the concordance between the triggering allergen and the prescribed indication.
  • Enhanced AAI education should focus on using the device for any anaphylaxis symptoms, irrespective of the specific trigger.